Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining and Modulating 'BRCAness'.

Andrea K Byrum1, Alessandro Vindigni2, Nima Mosammaparast1

  • 1Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA.

Trends in Cell Biology
|August 1, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.

Nature communications·2026
Same author

FET proteins and PARylation-dependent condensates promote replication fork reversal and genome stability.

Nature communications·2026
Same author

Condensin and topoisomerases cooperate to relieve topological stress at stalled replication forks.

Nature communications·2026
Same author

CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapy.

Journal of bone oncology·2026
Same author

The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.

bioRxiv : the preprint server for biology·2026
Same author

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Molecular cancer research : MCR·2026
Same journal

Horizontal transfer of mitochondria in cancer: The physiology reborn in disease?

Trends in cell biology·2026
Same journal

Spindle errors: A stress test for epithelial robustness.

Trends in cell biology·2026
Same journal

Multicellular ecosystems: Linking cellular diversity to tissue function and disease.

Trends in cell biology·2026
Same journal

Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

Trends in cell biology·2026
Same journal

Crashing by design: Utilizing DNA damage for MCC differentiation.

Trends in cell biology·2026
Same journal

The value of a shared lab: Our insights.

Trends in cell biology·2026
See all related articles

BRCAness, a cancer vulnerability, now includes replication fork protection defects. This broader definition expands therapeutic targets beyond BRCA1/2 loss, offering new strategies for treating proficient tumors with poly-(ADP)-ribose polymerase inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • BRCAness describes cancer's pathogenesis and vulnerability, traditionally linked to homologous recombination repair defects mimicking BRCA1 or BRCA2 loss.
  • BRCA-deficient cells exhibit genomic instability due to error-prone DNA repair, leading to sensitivity to DNA damaging agents and poly-(ADP)-ribose polymerase inhibitors (PARPis).

Purpose of the Study:

  • To broaden the definition of BRCAness beyond homologous recombination repair defects.
  • To incorporate replication fork protection (RFP) and related regulatory mechanisms into the concept of BRCAness.
  • To explore the synthetic lethality of these mechanisms with PARPis for novel therapeutic strategies.

Main Methods:

  • Review and synthesis of recent research expanding the mechanistic basis of BRCAness.
Keywords:
BRCA1BRCA2PARPchemotherapy resistancehomologous recombinationreplication fork protection

Related Experiment Videos

  • Highlighting discoveries in replication fork protection (RFP) regulation.
  • Examining the role of DNA damage checkpoint proteins and kinases in BRCA1/2 function.

    • Main Results:

    • Recent work has expanded BRCAness to include defects in replication fork protection (RFP).
    • Emerging mechanisms of RFP regulation, DNA damage checkpoints, and kinases offer new insights.
    • These mechanisms can induce synthetic lethality with PARPis.

    Conclusions:

    • The definition of BRCAness is broadened to encompass replication fork protection (RFP) defects.
    • These expanded mechanisms, including RFP regulation and related proteins, present new therapeutic targets.
    • Targeting these pathways with small molecule inhibitors could induce BRCAness in BRCA-proficient tumors, offering significant translational potential.